Publications 2025

Carlsen, S.E.L., Furulund, E., Arjmand, E.J., Fiskaaen, K.T.D., Vold, J.H., Madebo, T., Lid, T.G. and Fadnes, L.T., 2025. To smoothie or not to smoothie? A mixed-method approach of nutrition pilot intervention among individuals in opioid agonist treatment. BMC nutrition, 11(1), p.130.

Druckrey-Fiskaaen, K.T., Madebo, T., Carlsen, S.E.L., Furulund, E., Vold, J.H., Daltveit, J.T., Lid, T.G. and Fadnes, L.T., 2025. Multimethod feasibility evaluation of smoking cessation intervention for patients receiving opioid agonist therapy. Pilot and Feasibility Studies, 11(1), p.128.

Horndalsveen H, Haakensen VD, Madebo T, Grønberg BH, Halvorsen TO, Koivunen J, Oselin K, Cicenas S, Helbekkmo N, Aanerud M, Ahvonen J, Silvoniemi M, Bjaanæs MM, Farooqi S, Nebdal D, Dalsgaard AM, Danielsen BK, Børve M, Dalen TS, Öjlert ÅK, Helland Å. Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab. Front Oncol. 2025 Oct 22;15:1681420. doi: 10.3389/fonc.2025.1681420. PMID: 41199847; PMCID: PMC12586078.

Javadi Arjmand E, Thomassen LM, Druckrey-Fiskaaen KT, Furulund E, Vold JH, Madebo T, Blomhoff R, Daltveit JT, Henriksen HB, Chalabianloo F, Johansen KA, Lid TG, Fadnes LT; ATLAS4LAR study group. The effect of fruit smoothie supplementation on psychological distress and biomarkers among people with opioid dependence receiving opioid agonist therapy: a randomized controlled trial. BMC Med. 2025 Aug 29;23(1):505. doi: 10.1186/s12916-025-04347-w. PMID: 40877839; PMCID: PMC12395640.

Grønberg BH, Killingberg KT, Fløtten Ø, Bjaanæs MM, Brustugun OT, Madebo T, Langer SW, Risumlund SL, Schytte T, Helbekkmo N, Neumann K, Yksnøy Ø, Engleson J, Fluge S, Naustdal T, Giske LE, Nyman J, Tsakonas G, Halvorsen TO. High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial. J Thorac Oncol. 2025 Aug;20(8):1108-1119. doi:10.1016/j.jtho.2025.04.007. Epub 2025 Apr 19. PMID: 40258573.

Furulund E, Carlsen SL, Alpers SE, Vold JH, Druckrey-Fiskaaen KT, Madebo T, Dyrstad SM, Lid TG, Fadnes LT. Integrating an exercise program into opioid agonist therapy: a pilot study on feasibility, fitness improvements, and participation challenges. Addict Sci Clin Pract. 2025 Jul 8;20(1):52. doi:10.1186/s13722-025-00583-w. PMID: 40629478; PMCID: PMC12235965.

Carlsen SL, Furulund E, Arjmand EJ, Fiskaaen KTD, Vold JH, Madebo T, Lid TG, Fadnes LT; ATLAS4LAR and FruktBAR study group. To smoothie or not to smoothie? A mixed-method approach of nutrition pilot intervention among individuals in opioid agonist treatment. BMC Nutr. 2025 Jul 4;11(1):130. doi:10.1186/s40795-025-01095-1. PMID: 40616143; PMCID: PMC12228150.

Druckrey-Fiskaaen KT, Madebo T, Daltveit JT, Vold JH, Furulund E, Chalabianloo F, Gilje Lid T, Fadnes LT. Integrated Nicotine Replacement and Behavioral Support to Reduce Smoking in Opioid Agonist Therapy: A Randomized Clinical Trial. JAMA Psychiatry. 2025 Apr 1;82(4):406-414. doi:10.1001/jamapsychiatry.2024.4801. PMID: 39937506; PMCID: PMC11822603.

Publications 2024

Furulund E, Carlsen SL, Druckrey-Fiskaaen KT, Madebo T, Fadnes LT, Lid TG. A qualitative study of experiences with physical activity among people receiving opioid agonist therapy. Subst Abuse Treat Prev Policy. 2024 May 6;19(1):26. doi: 10.1186/s13011-024-00607-9. PMID: 38711108; PMCID: PMC11075283.

Furulund E, Druckrey-Fiskaaen KT, Carlsen SL, Madebo T, Fadnes LT, Lid TG. Healthy eating among people on opioid agonist therapy: a qualitative study of patients' experiences and perspectives. BMC Nutr. 2024 May 5;10(1):70. doi: 10.1186/s40795-024-00880-8. PMID: 38705977; PMCID: PMC11071228.

Druckrey-Fiskaaen KT, Vold JH, Madebo T, Midgard H, Dalgard O, Leiva RA, Fadnes LT; INTRO-HCV Study Group. Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study. Subst Abuse Treat Prev Policy. 2024 Mar 26;19(1):21. doi:10.1186/s13011-024-00603-z. PMID: 38532435; PMCID: PMC10964694.

Furulund E, Madebo T, Druckrey-Fiskaaen KT, Vold JH, Nordbotn MH, Dahl E, Dyrstad SM, Lid TG, Fadnes LT; ATLAS4LAR study group. Integrated exercise program in opioid agonist therapy clinics and effect on psychological distress: study protocol for a randomized controlled trial (BAReAktiv). Trials. 2024 Feb 29;25(1):155. doi: 10.1186/s13063-024-07993-2. PMID: 38424609; PMCID:PMC10905828.

Alpers SE, Druckrey-Fiskaaen KT, Madebo T, Vold JH, Pallesen S, Skogen JC, Lunde LH, Mæland S, Fadnes LT. The association of psychological distress and economic and health worries with tobacco smoking behavior during the COVID-19 pandemic: a two-year longitudinal cohort study. BMC Public Health. 2024 Feb 5;24(1):375. doi: 10.1186/s12889-024-17943-x. PMID: 38317145; PMCID: PMC10840189.

Druckrey-Fiskaaen KT, Madebo T, Daltveit JT, Vold JH, Furulund E, Lid TG, Fadnes LT. Update of statistical analysis plan for: Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR). Trials. 2024 Jan 6;25(1):29. doi: 10.1186/s13063-023-07894-w. PMID: 38184633; PMCID: PMC10770886.

Publications 2023

Orstad S, Fløtten Ø, Madebo T, Gulbrandsen P, Strand R, Lindemark F, Fluge S, Tilseth RH, Schaufel MA. "The challenge is the complexity" - A qualitative study about decision-making in advanced lung cancer treatment. Lung Cancer. 2023 Sep;183:107312. doi: 10.1016/j.lungcan.2023.107312. Epub 2023 Jul 20. PMID:37481888.

Druckrey-Fiskaaen KT, Furulund E, Madebo T, Carlsen SL, Fadnes LT, Lid TG; for ATLAS4LAR Study Group. A qualitative study on people with opioid use disorders' perspectives on smoking and smoking cessation interventions. Front Psychiatry. 2023 Aug 10;14:1185338. doi: 10.3389/fpsyt.2023.1185338. PMID: 37636821; PMCID: PMC10447904.

Publications 2022

Fadnes LT, Furulund E, Druckrey-Fiskaaen KT, Madebo T, Vold JH, Olsvold M, Pierron MC, Carlsen SL, Blomhoff R, Lid TG; ATLAS4LAR Study Group. Effect of fruit smoothie supplementation on psychological distress among people with substance use disorders receiving opioid agonist therapy: protocol for a

randomised controlled trial (FruktBAR). BMC Nutr. 2022 Sep 3;8(1):97. doi: 10.1186/s40795-022-00582-z. PMID: 36057629; PMCID: PMC9441043.

Druckrey-Fiskaaen KT, Furulund E, Daltveit JT, Vold JH, Lid TG, Madebo T, Fadnes LT; ATLAS4LAR Study Group. Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR). Trials. 2022 Aug

17;23(1):663. doi: 10.1186/s13063-022-06560-x. PMID: 35978355; PMCID:PMC9382815.

Madebo T, Bemanian M, Vold JH, Chowdhury R, Aas CF, Druckrey-Fiskaaen KT, Johansson KA, Fadnes LT. Vitamin B12 Levels, Substance Use Patterns and Clinical Characteristics among People with Severe Substance Use Disorders: A Cohort Study from Western Norway. Nutrients. 2022 May 5;14(9):1941. doi: 10.3390/nu14091941. PMID: 35565908; PMCID: PMC9105230.

Killingberg KT, Halvorsen TO, Fløtten Ø, Brustugun OT, Langer SW, Nyman J, Hornslien K, Madebo T, Schytte T, Risum S, Tsakonas G, Engleson J, Grønberg BH. Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer. Lung Cancer. 2022 Apr;166:49-57. doi: 10.1016/j.lungcan.2022.02.002. Epub 2022 Feb 8. PMID: 35183991.

Publications 2021

Furulund E, Bemanian M, Berggren N, Madebo T, Rivedal SH, Lid TG, Fadnes LT. Effects of Nutritional Interventions in Individuals with Chronic Obstructive Lung Disease: A Systematic Review of Randomized Controlled Trials. Int J Chron Obstruct Pulmon Dis. 2021 Nov 17;16:3145-3156. doi: 10.2147/COPD.S323736. PMID: 34819725; PMCID: PMC8607124.

Grønberg BH, Killingberg KT, Fløtten Ø, Brustugun OT, Hornslien K, Madebo T, Langer SW, Schytte T, Nyman J, Risum S, Tsakonas G, Engleson J, Halvorsen TO. High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. Lancet Oncol. 2021 Mar;22(3):321-331. doi: 10.1016/S1470-2045(20)30742-7. PMID: 33662285.

Publications 2020

Halvorsen TO, Stokke K, Killingberg KT, Raj SX, Sørhaug S, Brustugun OT, Fløtten Ø, Helbekkmo N, Hornslien K, Madebo T, Fluge S, Grønberg BH. Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Acta Oncol. 2020 Sep;59(9):1051-1057. doi: 10.1080/0284186X.2020.1778179. Epub 2020 Jun 16. PMID:32543258.

Publications 2018

Schein YL, Madebo T, Andersen HE, Arnesen TM, Dyrhol-Riise AM, Tveiten H, White RA, Winje BA. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study. BMC Infect Dis. 2018 Nov 19;18(1):587. doi:10.1186/s12879-018-3468-z. PMID: 30453946; PMCID: PMC6245849.

Publications 2015

Hjelstuen MH, Mjaaland I, Vikström J, Madebo T, Dybvik KI. Pulmonary function tests - an easy selection method for respiratory-gated radiotherapy in patients with left-sided breast cancer. Acta Oncol. 2015 Jul;54(7):1025-31. doi: 10.3109/0284186X.2014.990107. Epub 2014 Dec 31. PMID: 25549535.

Publications 2011-1993

Guo H, Liu JX, Xu L, Madebo T, Baak JP. Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapy. Integr Cancer Ther. 2011 Jun;10(2):127-37. doi: 10.1177/1534735410387599. Epub 2010 Dec 8. PMID: 21147812.

Madebo T, Lindtjørn B, Aukrust P, Berge RK. Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia. Am J Clin Nutr. 2003 Jul;78(1):117-22. doi: 10.1093/ajcn/78.1.117. PMID: 12816780.

Lindtjørn, Bernt, and Tesfaye Madebo. "The outcome of tuberculosis treatment at a rural hospital in southern Ethiopia." Tropical doctor 31.3 (2001): 132-135.

Madebo, Tesfaye, and Bernt Lindtjørn. "The impact of functional performance, HIV status, malnutrition, and clinical features on treatment outcomes of patients with pulmonary tuberculosis." Ethiopian Journal of Health Development 14.2 (2000): 177-182.

Madebo, T., and B. Lindtjorn. "Delay in treatment of pulmonary tuberculosis: an analysis of symptom duration among Ethiopian patients." MedGenMed: Medscape general medicine (1999): E6-E6.

Henriksen, Thor-Henrik, et al. "Peptic ulcer disease in south Ethiopia is strongly associated with Helicobacter pylori." Transactions of the royal society of tropical medicine and hygiene 93.2 (1999): 171-173.

Madebo, Tesfaye, Gunnar Nyæster, and Bernt Lindtjørn. "HIV infection and malnutrition change the clinical and radiological features of pulmonary tuberculosis." Scandinavian journal of infectious diseases 29.4 (1997): 355-359.

Henriksen, T. H., et al. "Rapid growth of Helicobacter pylori." European journal of clinical microbiology and infectious diseases. 14.11 (1995): 1008-1011. 

Tesfaye Madebo, Bernt Lindtjørn, Thor-Henrik Henriksen. High incidence of oesophagus and stomach cancers in the Bale highlands of south Ethiopia, Transactions of the Royal Society of Tropical Medicine and Hygiene, Volume 88, Issue 4, 1994, Page 415, ISSN 0035-9203, https://doi.org/10.1016/0035-9203(94)90407-3.

Madebo, Tesfaye. "A six month prospective study on different aspects of abortion." Ethiopian Medical Journal 31.3 (1993): 165-172.